Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1974 2
1976 3
1977 1
1978 3
1979 2
1980 2
1981 3
1982 4
1983 3
1984 2
1985 2
1986 1
1987 6
1988 6
1989 5
1990 5
1991 4
1992 8
1993 4
1994 8
1995 9
1996 10
1997 6
1998 11
1999 7
2000 10
2001 11
2002 12
2003 18
2004 19
2005 31
2006 37
2007 43
2008 26
2009 21
2010 33
2011 23
2012 35
2013 25
2014 24
2015 19
2016 18
2017 22
2018 18
2019 18
2020 18
2021 22
2022 24
2023 19
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

614 results

Results by year

Filters applied: . Clear all
Page 1
A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study.
Tam CS, Opat S, D'Sa S, Jurczak W, Lee HP, Cull G, Owen RG, Marlton P, Wahlin BE, Sanz RG, McCarthy H, Mulligan S, Tedeschi A, Castillo JJ, Czyz J, Fernández de Larrea C, Belada D, Libby E, Matous JV, Motta M, Siddiqi T, Tani M, Trneny M, Minnema MC, Buske C, Leblond V, Trotman J, Chan WY, Schneider J, Ro S, Cohen A, Huang J, Dimopoulos M. Tam CS, et al. Among authors: lee hp. Blood. 2020 Oct 29;136(18):2038-2050. doi: 10.1182/blood.2020006844. Blood. 2020. PMID: 32731259 Free PMC article. Clinical Trial.
Zanubrutinib Versus Ibrutinib in Symptomatic Waldenström Macroglobulinemia: Final Analysis From the Randomized Phase III ASPEN Study.
Dimopoulos MA, Opat S, D'Sa S, Jurczak W, Lee HP, Cull G, Owen RG, Marlton P, Wahlin BE, Garcia-Sanz R, McCarthy H, Mulligan S, Tedeschi A, Castillo JJ, Czyz J, Fernández de Larrea C, Belada D, Libby E, Matous J, Motta M, Siddiqi T, Tani M, Trněný M, Minnema MC, Buske C, Leblond V, Treon SP, Trotman J, Chan WY, Schneider J, Allewelt H, Patel S, Cohen A, Tam CS. Dimopoulos MA, et al. Among authors: lee hp. J Clin Oncol. 2023 Nov 20;41(33):5099-5106. doi: 10.1200/JCO.22.02830. Epub 2023 Jul 21. J Clin Oncol. 2023. PMID: 37478390 Clinical Trial.
Hydrogels with tunable stress relaxation regulate stem cell fate and activity.
Chaudhuri O, Gu L, Klumpers D, Darnell M, Bencherif SA, Weaver JC, Huebsch N, Lee HP, Lippens E, Duda GN, Mooney DJ. Chaudhuri O, et al. Among authors: lee hp. Nat Mater. 2016 Mar;15(3):326-34. doi: 10.1038/nmat4489. Epub 2015 Nov 30. Nat Mater. 2016. PMID: 26618884 Free PMC article.
Nano-bio interactions of 2D molybdenum disulfide.
Roy S, Deo KA, Singh KA, Lee HP, Jaiswal A, Gaharwar AK. Roy S, et al. Among authors: lee hp. Adv Drug Deliv Rev. 2022 Aug;187:114361. doi: 10.1016/j.addr.2022.114361. Epub 2022 May 27. Adv Drug Deliv Rev. 2022. PMID: 35636569 Review.
Dynamically crosslinked thermoresponsive granular hydrogels.
Lee HP, Cai KX, Wang TC, Davis R Jr, Deo K, Singh KA, Lele TP, Gaharwar AK. Lee HP, et al. J Biomed Mater Res A. 2023 Oct;111(10):1577-1587. doi: 10.1002/jbm.a.37556. Epub 2023 May 18. J Biomed Mater Res A. 2023. PMID: 37199446
Waxy Laryngeal Mass.
Lin YH, Lee HP, Lin MY. Lin YH, et al. Among authors: lee hp. JAMA Otolaryngol Head Neck Surg. 2015 Sep;141(9):853-4. doi: 10.1001/jamaoto.2015.1491. JAMA Otolaryngol Head Neck Surg. 2015. PMID: 26292059 No abstract available.
614 results